Lupin unit gets French regulatory nod for good manufacturing practices

| Updated on August 06, 2019 Published on August 07, 2019

Lupin says all its plants are governed by the same quality system   -  Bloomberg

Lupin on Tuesday announced the completion of the Good Manufacturing Practices (GMP) inspection of its finished products manufacturing facility (Unit-1) at Mandideep, by the French National Agency for Medicines and Health Products Safety (ANSM).

The inspection was conducted between April 8 and April 12. The ANSM inspection closed with no critical or major observations, Lupin said. Shares of Lupin closed 0.76 per cent lower at ₹750.90 on the BSE.

Published on August 07, 2019
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.